BAX – Baxter International Inc.
BAX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
7.4
Margin Of Safety %
56
Put/Call OI Ratio
0.91
EPS Next Q Diff
-0.01
EPS Last/This Y
3.79
EPS This/Next Y
0.14
Price
15.97
Target Price
20.64
Analyst Recom
2.78
Performance Q
-16.43
Upside
-236.8%
Beta
0.63
Ticker: BAX
16 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | BAX | 19.69 | 0.45 | 0.86 | 84246 |
| 2026-03-04 | BAX | 19.03 | 0.46 | 0.27 | 87495 |
| 2026-03-05 | BAX | 18.59 | 0.45 | 0.93 | 88080 |
| 2026-03-09 | BAX | 17.92 | 0.48 | 1.59 | 89690 |
| 2026-03-10 | BAX | 17.44 | 0.49 | 94.97 | 90842 |
| 2026-03-11 | BAX | 18.05 | 1.05 | 2.31 | 125720 |
| 2026-03-12 | BAX | 18.01 | 1.06 | 2.20 | 126731 |
| 2026-03-17 | BAX | 17.62 | 1.06 | 0.88 | 127203 |
| 2026-03-18 | BAX | 17.09 | 1.06 | 1.46 | 127781 |
| 2026-03-19 | BAX | 16.66 | 1.05 | 0.33 | 127652 |
| 2026-03-20 | BAX | 16.15 | 0.97 | 0.11 | 129808 |
| 2026-03-23 | BAX | 16.62 | 1.05 | 0.15 | 117219 |
| 2026-03-24 | BAX | 16.73 | 0.96 | 0.30 | 122468 |
| 2026-03-25 | BAX | 17.13 | 0.95 | 0.14 | 123240 |
| 2026-03-26 | BAX | 16.67 | 0.92 | 0.16 | 125819 |
| 2026-03-27 | BAX | 15.97 | 0.91 | 0.71 | 126417 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
16 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | BAX | 20.37 | -43.4 | 1480.1 | 1.92 |
| 2026-03-02 | BAX | 19.70 | -43.4 | 1347.4 | 1.92 |
| 2026-03-03 | BAX | 19.03 | -43.4 | 1347.3 | 1.92 |
| 2026-03-04 | BAX | 19.03 | -43.4 | 1368.8 | 1.92 |
| 2026-03-05 | BAX | 18.59 | -43.4 | 1354.2 | 1.92 |
| 2026-03-06 | BAX | 17.68 | -43.4 | 1337.7 | 1.92 |
| 2026-03-09 | BAX | 17.92 | -43.4 | 1377.5 | 1.92 |
| 2026-03-10 | BAX | 17.46 | -43.4 | 1353.4 | 1.92 |
| 2026-03-11 | BAX | 18.05 | -43.4 | 1389.9 | 1.92 |
| 2026-03-12 | BAX | 18.00 | -43.4 | 1367.4 | 1.92 |
| 2026-03-13 | BAX | 17.41 | -43.4 | 1348.2 | 1.92 |
| 2026-03-17 | BAX | 17.63 | -43.4 | 1388.8 | 1.92 |
| 2026-03-18 | BAX | 17.10 | -43.4 | 1350.8 | 1.92 |
| 2026-03-19 | BAX | 16.66 | -43.4 | 824.7 | 1.92 |
| 2026-03-20 | BAX | 16.15 | -43.1 | 823.3 | 1.92 |
| 2026-03-23 | BAX | 16.63 | -43.1 | 842.5 | 1.92 |
| 2026-03-24 | BAX | 16.72 | -43.1 | 835.1 | 1.92 |
| 2026-03-25 | BAX | 17.13 | -43.1 | 840.9 | 1.92 |
| 2026-03-26 | BAX | 16.66 | -43.1 | 824.1 | 1.92 |
| 2026-03-27 | BAX | 15.97 | -43.1 | 819.4 | 1.92 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | BAX | 0.00 | 7.19 | 8.37 |
| 2026-03-02 | BAX | 0.00 | 8.22 | 8.37 |
| 2026-03-03 | BAX | 0.00 | 8.22 | 8.37 |
| 2026-03-04 | BAX | 0.00 | 8.22 | 8.37 |
| 2026-03-05 | BAX | 0.00 | 8.22 | 8.37 |
| 2026-03-06 | BAX | 0.00 | 8.22 | 8.37 |
| 2026-03-09 | BAX | 0.00 | 7.67 | 8.37 |
| 2026-03-10 | BAX | 0.00 | 7.67 | 8.37 |
| 2026-03-11 | BAX | 0.00 | 7.67 | 7.53 |
| 2026-03-12 | BAX | 0.00 | 7.67 | 7.53 |
| 2026-03-13 | BAX | 0.00 | 7.67 | 7.53 |
| 2026-03-17 | BAX | 0.00 | 8.12 | 7.53 |
| 2026-03-18 | BAX | 0.00 | 8.12 | 7.53 |
| 2026-03-19 | BAX | 0.00 | 8.12 | 7.53 |
| 2026-03-20 | BAX | 0.00 | 8.12 | 7.53 |
| 2026-03-23 | BAX | 0.00 | 8.12 | 7.53 |
| 2026-03-24 | BAX | 0.00 | 8.12 | 7.53 |
| 2026-03-25 | BAX | 0.00 | 8.12 | 7.40 |
| 2026-03-26 | BAX | 0.00 | 8.12 | 7.40 |
| 2026-03-27 | BAX | 0.00 | 8.12 | 7.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.44
Avg. EPS Est. Current Quarter
0.31
Avg. EPS Est. Next Quarter
0.43
Insider Transactions
Institutional Transactions
8.12
Beta
0.63
Average Sales Estimate Current Quarter
2613
Average Sales Estimate Next Quarter
2824
Fair Value
24.98
Quality Score
41
Growth Score
49
Sentiment Score
20
Actual DrawDown %
82.2
Max Drawdown 5-Year %
-80.2
Target Price
20.64
P/E
Forward P/E
7.94
PEG
16.89
P/S
0.73
P/B
1.34
P/Free Cash Flow
24.75
EPS
-1.68
Average EPS Est. Cur. Y
1.92
EPS Next Y. (Est.)
2.06
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-7.68
Relative Volume
0.65
Return on Equity vs Sector %
-43
Return on Equity vs Industry %
-25.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
819.4
◆
BAX
Healthcare
$15.97
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
13/25
Volume
9/15
Valuation
18/20
TP/AR
0/10
Options
4/10
RSI
33.5
Range 1M
2.1%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
14/25
Growth
4/30
Estimates
2/20
Inst/Vol
5/15
Options
5/10
EPS Yr
-13.3%
EPS NY
5%
52W%
0.5%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+56.6% upside
Quality
4/30
Valuation
20/30
Growth
3/25
Stability
7/10
LT Trend
4/5
Upside
+56.6%
Quality
41
MoS
56%
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 37500
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
BAX
Latest News
—
Caricamento notizie per BAX…
stock quote shares BAX – Baxter International Inc. Stock Price stock today
news today BAX – Baxter International Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BAX – Baxter International Inc. yahoo finance google finance
stock history BAX – Baxter International Inc. invest stock market
stock prices BAX premarket after hours
ticker BAX fair value insiders trading